retatrutide trial update october 2025 Retatrutide: The Unapproved Drug America Already Takes Retatrutide and the Grey Market:

PlexusDx explores the science behind weight maintenance, genetic factors that influence regain risk, and practical long-term strategies to protect your results

Both compounds suppressed caloric intake, promoted a marked weight loss, improved glucose tolerance and reduced plasma cholesterol levels

Ozempic changed the conversation around weight loss in a way that almost nothing has in the past twenty years

FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of GLP-1 drugs from Novo Nordisk and Eli Lilly.

Learn about drug interactions with immunosuppressants, monitoring requirements, NHS guidance, and emerging clinical evidence for kidney, liver, and heart transplant recipients.